Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) EBIT Margin (2017 - 2026)

Updated

Crinetics Pharmaceuticals' EBIT Margin came in at -527.35% for Q2 2026, up 11995.64 percentage points from -12522.99% a year earlier and up 780.44 percentage points from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) EBIT Margin (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Crinetics Pharmaceuticals reported EBIT Margin of -1302.52%, up 29089.65 percentage points year-over-year; for FY2025, it was -6714.77%, up 25898.70 percentage points from FY2024.

  • EBIT Margin carries a five-year change of +98852.83 percentage points (FY2020 to FY2025).
  • Going back by year, EBIT Margin was -32613.47% in FY2024 (-27066.30 pp), -5547.17% in FY2023 (-2003.11 pp), -3544.06% in FY2022 (+6446.85 pp) and -9990.91% in FY2021 (+95576.70 pp).
  • The Q2 2026 figure represents the highest quarterly EBIT Margin since Q4 2017.
  • Year-over-year, EBIT Margin increased in three of the last four quarters, with an average year-over-year change of +7600.35 percentage points.
  • The fastest year-over-year change in EBIT Margin over five years came in Q1 2026 (a gain of 29552.32 percentage points), and the weakest in Q1 2025 (a drop of 19371.20 percentage points).
  • Business Quant data shows CRNX's EBIT Margin at -1307.79% (Q1 2026), -2169.55% (Q4 2025) and -99710.49% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -527.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -527.35%
Mar 31, 2026 -1,307.79%
Dec 31, 2025 -2,169.55%
Sep 30, 2025 -99,710.49%
Jun 30, 2025 -12,522.99%
Mar 31, 2025 -30,860.11%
Jun 30, 2024 -20,747.62%
Mar 31, 2024 -11,488.91%
Sep 30, 2023 -17,045.38%
Jun 30, 2023 -5,363.87%
Mar 31, 2023 -1,790.89%
Dec 31, 2022 -6,707.48%
Sep 30, 2022 -9,487.77%
Jun 30, 2022 -9,805.24%
Mar 31, 2022 -1,080.39%
Dec 31, 2021 -2,865.31%
Mar 31, 2020 -25,045.07%
Dec 31, 2019 -4,739.56%
Sep 30, 2019 -3,015.64%
Mar 31, 2019 -2,736.78%
API Access

Crinetics Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRNX&period=max&api_key=YOUR_API_KEY